Transcription Factors in Cancer

癌症中的转录因子

基本信息

  • 批准号:
    7270085
  • 负责人:
  • 金额:
    $ 178.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-23 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Marshall University in the final stages of the development of the Edwards Cancer Center. Through the generosity of the Edwards family, funds are being used to construct a cancer center building and to establish an endowment. The new Cancer Building is currently being constructed and will be primarily a diagnostic and treatment facility. In light of these developments we are establishing a Cancer Research Center (CRC) that will complement and interdigitate with the clinical component of the Edwards Cancer Center. As part of this CRC we are proposing a COBRE entitled "Transcription Factors in Cancer" The COBRE consists of four projects and three cores. Project 1: "Beta catenin function and retinoic acid in melanoma", Beverly, Delidow, Principal Investigator will build on preliminary findings that retinoic acd reduces nuclear content and function of beta-catenin in melanoma to explore the consequences of this multifunctional protein in progression of human melanoma. Project 2: "Retinoids, NF-kB and Mn-SOD in Neuroblastoma", Kelley Kiningham, PI. will explore the hypothesis that Mn-SOD is required for retinoid-induced differentiation and that reactive oxygen species are involved in signaling. Project 3 "Sap, a potential zebrafish oncogene", Maiyon Park, Principal Investigator investigates the exciting finding that overexpression of sap in zebrafish embryos leads to tumor formation and will determine if a human oncogene counterpart is present is some human tumors. Project 4: "The role of Ski/Sno in testicular cancer", Laura Richardson, PI, deals with overexpression and function of this transcription factor in testicular cancer. These projects are supported by Administrative, Imaging and Genomics Cores. All projects deal with retinoids or its signaling pathway in a least a portion of their research. Thus there will be a great deal of interaction regarding common assays and reagents. This critical mass of investigators working on a common scientific theme with multiple interactions, supported by strong cores provides a unique opportunity for both career development of COBRE investigators and development of a nationally competitive research center.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard M. Niles其他文献

Expression of TGF-β during in vitro differentiation of hamster tracheal epithelial cells
Adenylate cyclase activity in cultured epithelial cells
  • DOI:
    10.1007/bf02615137
  • 发表时间:
    1977-08-01
  • 期刊:
  • 影响因子:
    1.900
  • 作者:
    Richard M. Niles;Joseph S. Makarski;Nicholas Ballinger;Hwakyu Kim;Alexander M. Rutenburg
  • 通讯作者:
    Alexander M. Rutenburg
High extracellular fibrinolytic activity of tumors and control normal tissues
  • DOI:
    10.1016/s0006-291x(75)80216-6
  • 发表时间:
    1975-07-22
  • 期刊:
  • 影响因子:
  • 作者:
    Bakshy A. Chibber;Richard M. Niles;Liisa Prehn;Sam Sorof
  • 通讯作者:
    Sam Sorof
Retinoic acid-induced arrest of mouse melanoma cells in G1 without inhibition of protein synthesis

Richard M. Niles的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard M. Niles', 18)}}的其他基金

Bioengineering a non-pathogenic bacteria to produce medically-relevant biopolymers
对非致病性细菌进行生物工程以生产医学相关的生物聚合物
  • 批准号:
    8977656
  • 财政年份:
    2015
  • 资助金额:
    $ 178.1万
  • 项目类别:
Bioengineering a non-pathogenic bacteria to produce medically-relevant biopolymers
对非致病性细菌进行生物工程以生产医学相关的生物聚合物
  • 批准号:
    9345681
  • 财政年份:
    2015
  • 资助金额:
    $ 178.1万
  • 项目类别:
Transcription Factors in Cancer
癌症中的转录因子
  • 批准号:
    7900301
  • 财政年份:
    2009
  • 资助金额:
    $ 178.1万
  • 项目类别:
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=
马歇尔·U·科布雷:行政核心=
  • 批准号:
    7720780
  • 财政年份:
    2008
  • 资助金额:
    $ 178.1万
  • 项目类别:
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=
马歇尔·U·科布雷:行政核心=
  • 批准号:
    7610729
  • 财政年份:
    2007
  • 资助金额:
    $ 178.1万
  • 项目类别:
RARbeta in Melanoma: Epigenetic Regulation by Nutrients
黑色素瘤中的 RARbeta:营养素的表观遗传调控
  • 批准号:
    7291022
  • 财政年份:
    2006
  • 资助金额:
    $ 178.1万
  • 项目类别:
RARbeta in Melanoma: Epigenetic Regulation by Nutrients
黑色素瘤中的 RARbeta:营养素的表观遗传调控
  • 批准号:
    7179001
  • 财政年份:
    2006
  • 资助金额:
    $ 178.1万
  • 项目类别:
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=
马歇尔·U·科布雷:行政核心=
  • 批准号:
    7382179
  • 财政年份:
    2006
  • 资助金额:
    $ 178.1万
  • 项目类别:
MARSHALL U COBRE: ADMINISTRATIVE COREOIR=
马歇尔·U·科布雷:行政核心=
  • 批准号:
    7171401
  • 财政年份:
    2005
  • 资助金额:
    $ 178.1万
  • 项目类别:
Transcription Factors in Cancer
癌症中的转录因子
  • 批准号:
    7110385
  • 财政年份:
    2004
  • 资助金额:
    $ 178.1万
  • 项目类别:

相似国自然基金

生长素响应因子(Auxin Response Factors)在拟南芥雄配子发育中的功能研究
  • 批准号:
    31970520
  • 批准年份:
    2019
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目

相似海外基金

Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment
研究 GLI 转录因子作为胰腺癌微环境的调节剂
  • 批准号:
    10681714
  • 财政年份:
    2023
  • 资助金额:
    $ 178.1万
  • 项目类别:
Immunocompetent in vivo CRISPR screening to identify key transcription factors which enhance persistence and efficacy of CAR-T cells in cancer
免疫活性体内 CRISPR 筛选,以确定增强 CAR-T 细胞在癌症中的持久性和功效的关键转录因子
  • 批准号:
    MR/Y001184/1
  • 财政年份:
    2023
  • 资助金额:
    $ 178.1万
  • 项目类别:
    Research Grant
Mechanism of EMT activation of cancer stem cells by phase separation of transcription factors.
通过转录因子相分离激活癌症干细胞的EMT机制。
  • 批准号:
    23K08926
  • 财政年份:
    2023
  • 资助金额:
    $ 178.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Collaborative Activities of the Key Transcription Factors in Glioblastoma Stem-like Cancer Cells
胶质母细胞瘤干细胞样癌细胞中关键转录因子的协同活动
  • 批准号:
    10400674
  • 财政年份:
    2021
  • 资助金额:
    $ 178.1万
  • 项目类别:
Targeting MiT transcription factors as a novel therapeutic approach to disru pt the adaptive response to microenvironmental stresses that gives rise to d ormant and cancer stem cell
靶向 MiT 转录因子作为一种新的治疗方法,可破坏对微环境应激的适应性反应,从而产生休眠细胞和癌症干细胞
  • 批准号:
    21K15524
  • 财政年份:
    2021
  • 资助金额:
    $ 178.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer
用于治疗去势抵抗性前列腺癌的不可成药转录因子的多靶点纳米载体抑制剂
  • 批准号:
    10415002
  • 财政年份:
    2021
  • 资助金额:
    $ 178.1万
  • 项目类别:
Roles of endothelial-mesenchymal transition (EndoMT)-suppressing transcription factors in the inhibition of cancer progression
内皮间质转化(EndoMT)抑制转录因子在抑制癌症进展中的作用
  • 批准号:
    21K07094
  • 财政年份:
    2021
  • 资助金额:
    $ 178.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
E2F family transcription factors are directly regulated by TRIM28 to promote castration-resistance in prostate cancer
E2F家族转录因子受TRIM28直接调节促进前列腺癌去势抵抗
  • 批准号:
    10445046
  • 财政年份:
    2021
  • 资助金额:
    $ 178.1万
  • 项目类别:
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer
用于治疗去势抵抗性前列腺癌的不可成药转录因子的多靶点纳米载体抑制剂
  • 批准号:
    10252316
  • 财政年份:
    2021
  • 资助金额:
    $ 178.1万
  • 项目类别:
Development of anti-cancer agents and biomarkers that target intrinsically disordered regions of transcription factors and protein kinases
开发针对转录因子和蛋白激酶本质无序区域的抗癌药物和生物标志物
  • 批准号:
    2619050
  • 财政年份:
    2021
  • 资助金额:
    $ 178.1万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了